Portfolio Lab

CME Group Inc.

  • Stock
  • Ticker CME
  • ISIN US12572Q1058
  • Nasdaq

Financials · Exchanges, brokers and asset managers · USA

$307.56 +0.41%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of CME Group Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

CMEGlobal equities (VT)

$10,000 grew to $39,564. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −37.3% in 03/2020, measured from the peak in 03/2020. It took 14 months to get back to the old peak.

1-year return
+16.1%
5-year return p.a.
+11.2%
10-year return p.a.
+14.7%
Volatility p.a.
21.0%
Largest decline
−37.3%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue1,5251,6421,6921,5381,6491,8801,7061,737
Operating income9471,1081,1299731,0201,3101,1071,141
EBITDA9751,1351,1579991,0461,3371,1351,169
Net income8759561,0259081,1831,1541,0421,037
Earnings per share2.402.622.812.493.243.182.882.89
Balance sheet
Total assets137,447157,832179,907187,145198,424201,994194,677192,093
Liabilities110,960130,801152,168158,954169,696175,375168,156165,532
Equity26,48727,03127,73928,19028,72826,61826,52026,560
Cash2,8921,4051,9812,4474,4172,3912,1442,199
Cash flow
Operating cash flow1,0181,1171,0599681,1341,2609471,086
Capital expenditure-26-14-18-18-33-22-24-16
Free cash flow9921,1021,0409501,1011,2389241,070

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2017 at +32.3%, weakest 2022 at −22.9%. 7 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
23 Oct 2026$2.89
24 Jul 2026$2.88
24 Apr 2026$3.18
26 Feb 2026$3.24
24 Oct 2025$2.49
25 Jul 2025$2.81
30 Apr 2025$2.62
27 Feb 2025$2.40
8 Nov 2024$2.50
5 Aug 2024$2.42
1 May 2024$2.35
28 Feb 2024$2.24

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€100bn
Market cap in trading currency
$110bn
Enterprise value
–
P/E
25.2
P/S
15.82
P/B
4.15
EV/Sales
–
EV/EBITDA
–
Earnings yield
4.0%
FCF yield
–

Results (last four quarters)

Revenue
$6.97bn
Gross profit
–
EBITDA
–
Net income
$4.42bn
Earnings per share
$12.19
Revenue per share
$19.44
Revenue growth
+13.0%
Earnings growth
+14.2%

Profitability

Gross margin
–
Operating margin
82.8%
Net margin
63.3%
Return on equity
16.1%
Return on assets
2.3%

Balance sheet and cash flow

Cash
$2.33bn
Cash per share
$6.50
Financial debt
–
Debt/equity %
–
Current ratio
–
Book value per share
$74.06
Operating cash flow
–
Free cash flow
–

Dividend

Dividend yield
3.67%
Dividend (12 months)
$11.30
Yield (12 months)
3.67%
Payout ratio
93%
Ex-dividend date
9 Sep 2026

Shares and trading

Shares outstanding
359m
Volume
2.64m
Avg. volume 3 months
1.93m
Relative volume
1.4

Price and technicals

Price
$307.56
1 day
+0.4%
52-week high
$326.46
52-week low
$218.58
Distance to 52-week high
−5.8%
Distance to 52-week low
+40.7%
Distance to 50-day line
+6.3%
Distance to 200-day line
+9.1%
RSI (14)
55
Volatility 1M
25.0%

Performance

1 week
−3.3%
1 month
+0.5%
3 months
+10.2%
6 months
+5.6%
YTD
+12.6%
1 year
+12.9%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has CME performed since 11/2016?

$10,000 grew to $39,564 by 20 Nov 2026, which is +14.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is CME?

Volatility was 21.0% per year, measured on monthly returns. The largest decline from a peak was −37.3%, with the low in 03/2020.

How does CME compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, CME returned +14.8% at 21.0%. The correlation of monthly returns was 0.22; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

CME Group Inc. (CME): Return and risk | Portfolio Lab